Literature DB >> 11228449

Primary radiation therapy for early glottic cancer.

S W Barthel1, R M Esclamado.   

Abstract

OBJECTIVES/HYPOTHESIS: Early glottic squamous cell carcinoma can be effectively treated with either radiation or surgical intervention. We evaluated our experience treating early glottic cancer with primary radiation therapy and our vertical hemilaryngectomy (VHL) salvage experience. STUDY DESIGN/
METHODS: Retrospectively, patient records between January 1986 and December 1994 were reviewed and 45 patients with early glottic squamous cell carcinoma who received full-course radiation therapy at the Cleveland Clinic Foundation were identified.
RESULTS: Local control after radiation therapy was 80% overall, 87.5% for T1 lesions, and 75% for T2 lesions. Four patients underwent VHL for salvage after local recurrence; 1 was successfully salvaged with VHL. Five patients underwent total laryngectomy salvage after radiation therapy; all were successful. Only 1 of the 6 patients who were originally candidates for VHL before radiation therapy was successfully salvaged with the larynx preserved.
CONCLUSIONS: Our local control rates using primary radiation therapy are consistent with prior published series, but voice sparing salvage is poor.

Entities:  

Mesh:

Year:  2001        PMID: 11228449     DOI: 10.1067/mhn.2001.112574

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  10 in total

1.  Treatment and predictive factors in patients with recurrent laryngeal carcinoma: A retrospective study.

Authors:  Peijing Li; Weihan Hu; Yuan Zhu; Jianjiang Liu
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

2.  Management of the N0 neck in recurrent laryngeal squamous cell carcinoma.

Authors:  Pei-Jing Li; Wei-Han Hu; Ting Jin
Journal:  Mol Clin Oncol       Date:  2015-10-29

3.  Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx.

Authors:  Ichiro Tateya; Shigeru Hirano; Hisayoshi Kojima; Koichi Omori; Kazuhiko Shoji; Michihide Mitsumori; Yasushi Nagata; Juichi Ito
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-07-13       Impact factor: 2.503

4.  [Glottic laryngeal carcinoma. Tis, T1 and T2--long term results after laser resection].

Authors:  O König; U Bockmühl; K Haake
Journal:  HNO       Date:  2006-02       Impact factor: 1.284

5.  Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer.

Authors:  Yoshiyuki Itoh; Nobukazu Fuwa
Journal:  Radiat Med       Date:  2006-05

6.  Functional organ preservation in laryngeal and hypopharyngeal cancer.

Authors:  Petra Ambrosch; Asita Fazel
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

7.  Transoral treatment strategies for head and neck tumors.

Authors:  Christoph Arens
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

8.  Oncological and functional outcome after surgical treatment of early glottic carcinoma without anterior commissure involvement.

Authors:  Jovica Milovanovic; Ana Jotic; Vojko Djukic; Bojan Pavlovic; Aleksandar Trivic; Sanja Krejovic-Trivic; Andjela Milovanovic; Aleksandar Milovanovic; Vera Artiko; Bojan Banko
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

9.  A potential panel of two-long non-coding RNA signature to predict recurrence of patients with laryngeal cancer.

Authors:  Zhigang Bai; Enhong Shi; Qiwei Wang; Zhouwei Dong; Ping Xu
Journal:  Oncotarget       Date:  2017-06-28

10.  Risk of Recurrence in Laryngeal Cancer.

Authors:  Jesper Brandstorp-Boesen; Ragnhild Sørum Falk; Jan Folkvard Evensen; Morten Boysen; Kjell Brøndbo
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.